| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |